Skip to main content

Animations

MJFF Publications

2651 - 2660 of 7915 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • RESTRICTED
    Title: Aducanumab: look before leaping
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5
    Best OA location URL:
    Citation Count: 11
  • OPEN
    Title: Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01240-4
    Citation Count: 37
  • OPEN
    Title: “Real‐Life” Remote Dystonia Assessment: Feasibility, Accuracy, and Practice Implications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13330
    Citation Count: 1
  • RESTRICTED
    Title: Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28759
    Best OA location URL:
    Citation Count: 22
  • OPEN
    Title: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28749
    Citation Count: 25
  • RESTRICTED
    Title: Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020
    Journal Name: Operative Neurosurgery
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/ons/opab261
    Best OA location URL:
    Citation Count: 12
  • OPEN
    Title: Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient Rats
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.655901
    Citation Count: 1
  • OPEN
    Title: Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects
    Journal Name: Current Medical Research and Opinion
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/03007995.2021.1965975
    Citation Count: 8
  • OPEN
    Title: Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00872-x
    Citation Count: 45
  • OPEN
    Title: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    Journal Name: Pharmacogenetics and Genomics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.